标普生物科技LOF(161127)
动态评分： 6.09分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2021-12-31 | DCPH | Deciphera Pharmaceuticals Inc | 买入 | 173.55 | 1.94% |
| 2021-12-31 | EBS | Emergent BioSolutions Inc | 买入 | 170.24 | 1.9% |
| 2021-12-31 | NVAX | 诺瓦瓦克斯医药 | 买入 | 170.11 | 1.9% |
| 2021-12-31 | CRIS | 居里 | 买入 | 168.63 | 1.88% |
| 2021-12-31 | ARCT | Arcturus Therapeutics Holdings Inc | 买入 | 165.91 | 1.85% |
| 2021-12-31 | SAGE | Sage Therapeutics Inc | 买入 | 163.96 | 1.83% |
| 2021-12-31 | NVTA | Invitae Corp | 买入 | 162.16 | 1.81% |
| 2021-06-30 | IBRX | ImmunityBio Inc | 买入 | 161.64 | 1.81% |
| 2021-06-30 | CRIS | 居里 | 买入 | 153.61 | 1.72% |
| 2021-06-30 | CCXI | ChemoCentryx Inc | 买入 | 151.23 | 1.69% |
| 2021-06-30 | OCGN | Ocugen Inc | 买入 | 137.13 | 1.53% |
| 2021-06-30 | DMTK | DermTech Inc | 买入 | 135.75 | 1.52% |
| 2021-06-30 | LGND | Ligand Pharmaceuticals Inc | 买入 | 122.54 | 1.37% |
| 2021-06-30 | HGEN | Humanigen Inc | 买入 | 121.91 | 1.36% |
| 2021-06-30 | VIR | Vir Biotechnology Inc | 买入 | 121.64 | 1.36% |
| 2021-06-30 | AVXL | Anavex Life Sciences Corp | 买入 | 119.48 | 1.34% |
| 2021-06-30 | ALT | Altimmune Inc | 买入 | 116.35 | 1.3% |
| 2021-06-30 | IMVT | Immunovant Inc | 买入 | 116.48 | 1.3% |
| 2021-06-30 | NVAX | 诺瓦瓦克斯医药 | 买入 | 116.62 | 1.3% |
| 2021-06-30 | ORGO | Organogenesis Holdings Inc-A | 买入 | 115.57 | 1.29% |
公告&资料
